| 000 | 01022 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517134723.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2056-5933 | ||
| 024 | 7 |
_a10.1136/rmdopen-2016-000292 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRose, Thomas | |
| 245 | 0 | 0 |
_aSIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. _h[electronic resource] |
| 260 |
_bRMD open _c2016 |
||
| 300 |
_ae000292 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aSzelinski, Franziska | |
| 700 | 1 | _aLisney, Anna | |
| 700 | 1 | _aReiter, Karin | |
| 700 | 1 | _aFleischer, Sarah J | |
| 700 | 1 | _aBurmester, Gerd R | |
| 700 | 1 | _aRadbruch, Andreas | |
| 700 | 1 | _aHiepe, Falk | |
| 700 | 1 | _aGrützkau, Andreas | |
| 700 | 1 | _aBiesen, Robert | |
| 700 | 1 | _aDörner, Thomas | |
| 773 | 0 |
_tRMD open _gvol. 2 _gno. 2 _gp. e000292 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/rmdopen-2016-000292 _zAvailable from publisher's website |
| 999 |
_c26819334 _d26819334 |
||